This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Ahlquist DA, Zou H, Domanico M, Mahoney DW, Yab TC, Taylor WR, Butz ML, Thibodeau SN, Rabeneck L, Paszat LF, et al. Next-generation stool DNA test accurately detects colorectal cancer and large adenomas. Gastroenterology. 2012 Feb;142(2):248–256. https://doi.org/10.1053/j.gastro.2011.10.031AhlquistDAZouHDomanicoMMahoneyDWYabTCTaylorWRButzMLThibodeauSNRabeneckLPaszatLFNext-generation stool DNA test accurately detects colorectal cancer and large adenomas. Gastroenterology. 2012Feb;142(2):248–256. https://doi.org/10.1053/j.gastro.2011.10.031Search in Google Scholar
Aitchison A, Pearson JF, Purcell RV, Frizelle FA, Keenan JI. Detection of Fusobacterium nucleatum DNA in primary care patient stool samples does not predict progression of colorectal neoplasia. PLoS One. 2022 Jun;17(6):e0269541. https://doi.org/10.1371/journal.pone.0269541AitchisonAPearsonJFPurcellRVFrizelleFAKeenanJI.Detection of Fusobacterium nucleatum DNA in primary care patient stool samples does not predict progression of colorectal neoplasia. PLoS One. 2022Jun;17(6):e0269541. https://doi.org/10.1371/jour-nal.pone.0269541Search in Google Scholar
Borozan I, Zaidi SH, Harrison TA, Phipps AI, Zheng J, Lee S, Trinh QM, Steinfelder RS, Adams J, Banbury BL, et al. Molecular and pathology features of colorectal tumors and patient outcomes are associated with Fusobacterium nucleatum and its subspecies animalis. Cancer Epidemiol Biomarkers Prev. 2022 Jan;31(1):210–220. https://doi.org/10.1158/1055-9965.epi-21-0463BorozanIZaidiSHHarrisonTAPhippsAIZhengJLeeSTrinhQMSteinfelderRSAdamsJBanburyBLMolecular and pathology features of colorectal tumors and patient outcomes are associated with Fusobacterium nucleatum and its subspecies animalis. Cancer Epidemiol Biomarkers Prev. 2022Jan;31(1):210–220. https://doi.org/10.1158/1055-9965.epi-21-0463Search in Google Scholar
Bosch LJ, Carvalho B, Fijneman RJ, Jimenez CR, Pinedo HM, van Engeland M, Meijer GA. Molecular tests for colorectal cancer screening. Clin Colorectal Cancer. 2011 Mar;10(1):8–23. https://doi.org/10.3816/ccc.2011.n.002BoschLJCarvalhoBFijnemanRJJimenezCRPinedoHMvan EngelandMMeijerGA.Molecular tests for colorectal cancer screening. Clin Colorectal Cancer. 2011Mar;10(1):8–23. https://doi.org/10.3816/ccc.2011.n.002Search in Google Scholar
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394–424. https://doi.org/10.3322/caac.21492BrayFFerlayJSoerjomataramISiegelRLTorreLAJemalA.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018Nov;68(6):394–424. https://doi.org/10.3322/caac.21492Search in Google Scholar
Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK, Varambally S. UAL-CAN: A portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017 Aug;19(8):649–658. https://doi.org/10.1016/j.neo.2017.05.002ChandrashekarDSBashelBBalasubramanyaSAHCreightonCJPonce-RodriguezIChakravarthiBVSKVaramballyS.UAL-CAN: A portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017Aug;19(8):649–658. https://doi.org/10.1016/j.neo.2017.05.002Search in Google Scholar
Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, Athar M, Netto GJ, Qin ZS, Kumar S, Manne U, et al. UALCAN: An update to the integrated cancer data analysis platform. Neoplasia. 2022 Mar;25:18–27. https://doi.org/10.1016/j.neo.2022.01.001ChandrashekarDSKarthikeyanSKKorlaPKPatelHShovonARAtharMNettoGJQinZSKumarSManneUUALCAN: An update to the integrated cancer data analysis platform. Neoplasia. 2022Mar;25:18–27. https://doi.org/10.1016/j.neo.2022.01.001Search in Google Scholar
Datorre JG, Dos Reis MB, de Carvalho AC, Porto J, Rodrigues GH, Lima AB, Reis MT, Hirai W, Hashimoto CL, Guimarães DP, et al. Enhancing colorectal cancer screening with droplet digital PCR analysis of Fusobacterium nucleatum in fecal immunochemical test samples. Cancer Prev Res (Phila). 2024 Oct;17(10):471–479. https://doi.org/10.1158/1940-6207.capr-23-0331DatorreJGDos ReisMBde CarvalhoACPortoJRodriguesGHLimaABReisMTHiraiWHashimotoCLGuimarãesDPEnhancing colorectal cancer screening with droplet digital PCR analysis of Fusobacterium nucleatum in fecal immunochemical test samples. Cancer Prev Res (Phila). 2024Oct;17(10):471–479. https://doi.org/10.1158/1940-6207.capr-23-0331Search in Google Scholar
Dohlman AB, Arguijo Mendoza D, Ding S, Gao M, Dressman H, Iliev ID, Lipkin SM, Shen X. The cancer microbiome atlas: a pan-cancer comparative analysis to distinguish tissue-resident microbiota from contaminants. Cell Host Microbe. 2021 Feb;29(2):281–298.e5. https://doi.org/10.1016/j.chom.2020.12.001DohlmanABArguijo MendozaDDingSGaoMDressmanHIlievIDLipkinSMShenX.The cancer microbiome atlas: a pan-cancer comparative analysis to distinguish tissue-resident microbiota from contaminants. Cell Host Microbe. 2021Feb;29(2):281–298.e5. https://doi.org/10.1016/j.chom.2020.12.001Search in Google Scholar
Fardini Y, Wang X, Témoin S, Nithianantham S, Lee D, Shoham M, Han YW. Fusobacterium nucleatum adhesin FadA binds vascular endothelial cadherin and alters endothelial integrity. Mol Microbiol. 2011 Dec;82(6):1468–1480. https://doi.org/10.1111/j.1365-2958.2011.07905.xFardiniYWangXTémoinSNithiananthamSLeeDShohamMHanYW.Fusobacterium nucleatum adhesin FadA binds vascular endothelial cadherin and alters endothelial integrity. Mol Microbiol. 2011Dec;82(6):1468–1480. https://doi.org/10.1111/j.1365-2958.2011.07905.xSearch in Google Scholar
Gao Y, Bi D, Xie R, Li M, Guo J, Liu H, Guo X, Fang J, Ding T, Zhu H, et al. Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer. Signal Transduct Target Ther. 2021 Nov 19;6(1):398. https://doi.org/10.1038/s41392-021-00795-xGaoYBiDXieRLiMGuoJLiuHGuoXFangJDingTZhuHFusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer. Signal Transduct Target Ther. 2021Nov19;6(1):398. https://doi.org/10.1038/s41392-021-00795-xSearch in Google Scholar
Hua R, Yu J, Yan X, Ni Q, Zhi X, Li X, Jiang B, Zhu J. Syndecan-2 in colorectal cancer plays oncogenic role via epithelial-mesenchymal transition and MAPK pathway. Biomed Pharmacother. 2020 Jan;121:109630. https://doi.org/10.1016/j.biopha.2019.109630HuaRYuJYanXNiQZhiXLiXJiangBZhuJ.Syndecan-2 in colorectal cancer plays oncogenic role via epithelial-mesenchymal transition and MAPK pathway. Biomed Pharmacother. 2020Jan;121:109630. https://doi.org/10.1016/j.biopha.2019.109630Search in Google Scholar
Huang S, Yang Z, Zou D, Dong D, Liu A, Liu W, Huang L. Rapid detection of nusG and fadA in Fusobacterium nucleatum by loop-mediated isothermal amplification. J Med Microbiol. 2016 Aug;65(8):760–769. https://doi.org/10.1099/jmm.0.000300HuangSYangZZouDDongDLiuALiuWHuangL.Rapid detection of nusG and fadA in Fusobacterium nucleatum by loop-mediated isothermal amplification. J Med Microbiol. 2016Aug;65(8):760–769. https://doi.org/10.1099/jmm.0.000300Search in Google Scholar
Ikegami A, Chung P, Han YW. Complementation of the fadA mutation in Fusobacterium nucleatum demonstrates that the surface-exposed adhesin promotes cellular invasion and placental colonization. Infect Immun. 2009 Jul;77(7):3075–3079. https://doi.org/10.1128/iai.00209-09IkegamiAChungPHanYW.Complementation of the fadA mutation in Fusobacterium nucleatum demonstrates that the surface-exposed adhesin promotes cellular invasion and placental colonization. Infect Immun. 2009Jul;77(7):3075–3079. https://doi.org/10.1128/iai.00209-09Search in Google Scholar
Irrazábal T, Belcheva A, Girardin SE, Martin A, Philpott DJ. The multifaceted role of the intestinal microbiota in colon cancer. Mol Cell. 2014 Apr;54(2):309–320. https://doi.org/10.1016/j.mol-cel.2014.03.039IrrazábalTBelchevaAGirardinSEMartinAPhilpottDJ.The multifaceted role of the intestinal microbiota in colon cancer. Mol Cell. 2014Apr;54(2):309–320. https://doi.org/10.1016/j.mol-cel.2014.03.039Search in Google Scholar
Issa IA, Noureddine M. Colorectal cancer screening: An updated review of the available options. World J Gastroenterol. 2017 Jul;23(28):5086–5096. https://doi.org/10.3748/wjg.v23.i28.5086IssaIANoureddineM.Colorectal cancer screening: An updated review of the available options. World J Gastroenterol. 2017Jul;23(28):5086–5096. https://doi.org/10.3748/wjg.v23.i28.5086Search in Google Scholar
Leporrier J, Maurel J, Chiche L, Bara S, Segol P, Launoy G. A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg. 2006 Apr;93(4):465–474. https://doi.org/10.1002/bjs.5278LeporrierJMaurelJChicheLBaraSSegolPLaunoyG.A population-based study of theincidence management and prognosis of hepatic metastases from colorectal cancer. Br J Surg. 2006Apr;93(4):465–474. https://doi.org/10.1002/bjs.5278Search in Google Scholar
Li B, Liu S, Gao Y, Zheng L, Lu Y. Combined detection of SDC2/ADHFE1/PPP2R5C methylation in stool DNA for colorectal cancer screening. J Cancer Res Clin Oncol. 2023 Sep;149(12):10241–10253. https://doi.org/10.1007/s00432-023-04943-4LiBLiuSGaoYZhengLLuY.Combined detection of SDC2/ADHFE1/PPP2R5C methylation in stool DNA for colorectal cancer screening. J Cancer Res Clin Oncol. 2023Sep;149(12):10241–10253. https://doi.org/10.1007/s00432-023-04943-4Search in Google Scholar
Li B, Severson E, Pignon JC, Zhao H, Li T, Novak J, Jiang P, Shen H, Aster JC, Rodig S, Signoretti S, Liu JS, Liu XS. Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. Genome Biol. 2016 Aug 22;17(1):174. https://doi.org/10.1186/s13059-016-1028-7LiBSeversonEPignonJCZhaoHLiTNovakJJiangPShenHAsterJCRodigSSignorettiSLiuJSLiuXS.Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. Genome Biol. 2016Aug22;17(1):174. https://doi.org/10.1186/s13059-016-1028-7Search in Google Scholar
Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, Li B, Liu XS. TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017 Nov;77(21):e108–e110. https://doi.org/10.1158/0008-5472.CAN-17-0307LiTFanJWangBTraughNChenQLiuJSLiBLiuXS.TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017Nov;77(21):e108–e110. https://doi.org/10.1158/0008-5472.CAN-17-0307Search in Google Scholar
Mima K, Nishihara R, Qian ZR, Cao Y, Sukawa Y, Nowak JA, Yang J, Dou R, Masugi Y, Song M, et al. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut. 2016 Dec;65(12):1973–1980. https://doi.org/10.1136/gut-jnl-2015-310101MimaKNishiharaRQianZRCaoYSukawaYNowakJAYangJDouRMasugiYSongMFusobacterium nu-cleatum in colorectal carcinoma tissue and patient prognosis. Gut. 2016Dec;65(12):1973–1980. https://doi.org/10.1136/gut-jnl-2015-310101Search in Google Scholar
Nguyen LH, Goel A, Chung DC. Pathways of colorectal carcinogenesis. Gastroenterology. 2020 Jan;158(2):291–302. https://doi.org/10.1053/j.gastro.2019.08.059NguyenLHGoelAChungDC.Pathways of colorectal carcinogenesis. Gastroenterology. 2020Jan;158(2):291–302. https://doi.org/10.1053/j.gastro.2019.08.059Search in Google Scholar
Niu F, Wen J, Fu X, Li C, Zhao R, Wu S, Yu H, Liu X, Zhao X, Liu S, et al. Stool DNA test of methylated Syndecan-2 for the early detection of colorectal neoplasia. Cancer Epidemiol Biomarkers Prev. 2017 Sep;26(9):1411–1419. https://doi.org/10.1158/1055-9965.epi-17-0153NiuFWenJFuXLiCZhaoRWuSYuHLiuXZhaoXLiuSStool DNA test of methylated Syndecan-2 for the early detection of colorectal neoplasia. Cancer Epidemiol Biomarkers Prev. 2017Sep;26(9):1411–1419. https://doi.org/10.1158/1055-9965.epi-17-0153Search in Google Scholar
Oberwalder M, Zitt M, Wöntner C, Fiegl H, Goebel G, Zitt M, Köhle O, Mühlmann G, Ofner D, Margreiter R, et al. SFRP2 methylation in fecal DNA – a marker for colorectal polyps. Int J Colorectal Dis. 2008 Jan;23(1):15–19. https://doi.org/10.1007/s00384-007-0355-2OberwalderMZittMWöntnerCFieglHGoebelGZittMKöhleOMühlmannGOfnerDMargreiterRSFRP2 methylation in fecal DNA – a marker for colorectal polyps. Int J Colorectal Dis. 2008Jan;23(1):15–19. https://doi.org/10.1007/s00384-007-0355-2Search in Google Scholar
Osborn NK, Ahlquist DA. Stool screening for colorectal cancer: Molecular approaches. Gastroenterology. 2005 Jan;128(1):192–206. https://doi.org/10.1053/j.gastro.2004.10.041OsbornNKAhlquistDA.Stool screening for colorectal cancer: Molecular approaches. Gastroenterology. 2005Jan;128(1):192–206. https://doi.org/10.1053/j.gastro.2004.10.041Search in Google Scholar
Park H, Kim Y, Lim Y, Han I, Oh ES. Syndecan-2 mediates adhesion and proliferation of colon carcinoma cells. J Biol Chem. 2002 Aug 16;277(33):29730–29736. https://doi.org/10.1074/jbc.M202435200ParkHKimYLimYHanIOhES.Syndecan-2 mediates adhesion and proliferation of colon carcinoma cells. J Biol Chem. 2002Aug16;277(33):29730–29736. https://doi.org/10.1074/jbc.M202435200Search in Google Scholar
Pawa N, Arulampalam T, Norton JD. Screening for colorectal cancer: established and emerging modalities. Nat Rev Gastroenterol Hepatol. 2011 Nov 1;8(12):711–722. https://doi.org/10.1038/nrgastro.2011.205PawaNArulampalamTNortonJD.Screening for colorectal cancer: established and emerging modalities. Nat Rev Gastroenterol Hepatol. 2011Nov1;8(12):711–722. https://doi.org/10.1038/nrgastro.2011.205Search in Google Scholar
R Core Team. A language and environment for statistical computing. Vienna (Austria): R Foundation for Statistical Computing; 2022 [cited 2025 Jan 15]. Available from https://www.r-project.orgR Core TeamA language and environment for statistical computing. Vienna (Austria): R Foundation for Statistical Computing; 2022 [cited 2025 Jan 15]. Available from https://www.r-project.orgSearch in Google Scholar
Rabeneck L, Paszat LF, Hilsden RJ, Saskin R, Leddin D, Grunfeld E, Wai E, Goldwasser M, Sutradhar R, Stukel TA. Bleeding and perforation after outpatient colonoscopy and their risk factors in usual clinical practice. Gastroenterology. 2008 Dec;135(6):1899–1906.e1. https://doi.org/10.1053/j.gastro.2008.08.058RabeneckLPaszatLFHilsdenRJSaskinRLeddinDGrunfeldEWaiEGoldwasserMSutradharRStukelTA.Bleeding and perforation after outpatient colonoscopy and their risk factors in usual clinical practice. Gastroenterology. 2008Dec;135(6):1899–1906.e1. https://doi.org/10.1053/j.gastro.2008.08.058Search in Google Scholar
Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe. 2013 Aug;14(2):195–206. https://doi.org/10.1016/j.chom.2013.07.012RubinsteinMRWangXLiuWHaoYCaiGHanYW.Fuso-bacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe. 2013Aug;14(2):195–206. https://doi.org/10.1016/j.chom.2013.07.012Search in Google Scholar
Ruf F, Schreck C, Wagner A, Grziwok S, Pagel C, Romero S, Kies-linger M, Shimono A, Peschel C, Götze KS, et al. Loss of Sfrp2 in the niche amplifies stress-induced cellular responses, and impairs the in vivo regeneration of the hematopoietic stem cell pool. Stem Cells. 2016 Sep;34(9):2381–2392. https://doi.org/10.1002/stem.2416RufFSchreckCWagnerAGrziwokSPagelCRomeroSKies-lingerMShimonoAPeschelCGötzeKSLoss of Sfrp2 in the niche amplifies stress-induced cellularresponses and impairs the in vivo regeneration of the hematopoietic stem cell pool. Stem Cells. 2016Sep;34(9):2381–2392. https://doi.org/10.1002/stem.2416Search in Google Scholar
Tinmouth J, Lansdorp-Vogelaar I, Allison JE. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know. Gut. 2015 Aug;64(8):1327–1337. https://doi.org/10.1136/gutjnl-2014-308074TinmouthJLansdorp-VogelaarIAllisonJE.Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know. Gut. 2015Aug;64(8):1327–1337. https://doi.org/10.1136/gutjnl-2014-308074Search in Google Scholar
Vedeld HM, Goel A, Lind GE. Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives. Semin Cancer Biol. 2018 Aug;51:36–49. https://doi.org/10.1016/j.semcancer.2017.12.004VedeldHMGoelALindGE.Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives. Semin Cancer Biol. 2018Aug;51:36–49. https://doi.org/10.1016/j.semcan-cer.2017.12.004Search in Google Scholar
Wu Y, Jiao N, Zhu R, Zhang Y, Wu D, Wang AJ, Fang S, Tao L, Li Y, Cheng S, et al. Identification of microbial markers across populations in early detection of colorectal cancer. Nat Commun. 2021 May;12(1):3063. https://doi.org/10.1038/s41467-021-23265-yWuYJiaoNZhuRZhangYWuDWangAJFangSTaoLLiYChengSIdentification of microbial markers across populations in early detection of colorectal cancer. Nat Commun. 2021May;12(1):3063. https://doi.org/10.1038/s41467-021-23265-ySearch in Google Scholar
Yachida S, Mizutani S, Shiroma H, Shiba S, Nakajima T, Sakamoto T, Watanabe H, Masuda K, Nishimoto Y, Kubo M, et al. Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer. Nat Med. 2019 Jun;25(6):968–976. https://doi.org/10.1038/s41591-019-0458-7YachidaSMizutaniSShiromaHShibaSNakajimaTSakamotoTWatanabeHMasudaKNishimotoYKuboMMetagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer. Nat Med. 2019Jun;25(6):968–976. https://doi.org/10.1038/s41591-019-0458-7Search in Google Scholar
Zhang Q, Yu K, Li S, Zhang X, Zhao Q, Zhao X, Liu Z, Cheng H, Liu ZX, Li X. gutMEGA: A database of the human gut MEtaGenome Atlas. Brief Bioinform. 2021 May;22(3):bbaa082. https://doi.org/10.1093/bib/bbaa082ZhangQYuKLiSZhangXZhaoQZhaoXLiuZChengHLiuZXLiX.gutMEGA: A database of the human gut MEtaGenome Atlas. Brief Bioinform. 2021May;22(3):bbaa082. https://doi.org/10.1093/bib/bbaa082Search in Google Scholar
Zhao G, Liu X, Liu Y, Li H, Ma Y, Li S, Zhu Y, Miao J, Xiong S, Fei S, et al. Aberrant DNA methylation of SEPT9 and SDC2 in stool specimens as an integrated biomarker for colorectal cancer early detection. Front Genet. 2020 Jun;11:643. https://doi.org/10.3389/fgene.2020.00643ZhaoGLiuXLiuYLiHMaYLiSZhuYMiaoJXiongSFeiSAberrant DNA methylation of SEPT9 and SDC2 in stool specimens as an integrated biomarker for colorectal cancer early detection. Front Genet. 2020Jun;11:643. https://doi.org/10.3389/fgene.2020.00643Search in Google Scholar
Zhao G, Liu X, Liu Y, Ma Y, Yang J, Li H, Xiong S, Fei S, Zheng M, Zhao X. Methylated SFRP2 and SDC2 in stool specimens for colorectal cancer early detection: A cost-effective strategy for Chinese population. J Cancer. 2021 Mar;12(9):2665–2672. https://doi.org/10.7150/jca.52478ZhaoGLiuXLiuYMaYYangJLiHXiongSFeiSZhengMZhaoX.Methylated SFRP2 and SDC2 in stool specimens for colorectal cancer early detection: A cost-effective strategy for Chinese population. J Cancer. 2021Mar;12(9):2665–2672. https://doi.org/10.7150/jca.52478Search in Google Scholar